Midodrine helps cirrhotic patients live longer, data show

08/8/2011 | Medscape (free registration)

Long-term treatment with midodrine in addition to standard medical care increased survival and improved ascites control for cirrhotic patients in a pilot study of 40 patients reported in the Journal of Hepatology. Patients in the treatment group had increases in average arterial pressure, urinary volume and urine sodium excretion, and demonstrated a drop in plasma renin activity and plasma aldosterone concentrations.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI